GO:0019478 D-amino acid catabolic process: Breakdown Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019478 D-amino acid catabolic process describes the chemical reactions and pathways that break down D-enantiomers of amino acids, which are distinct from the more common L-amino acids.
• D-amino acids are generated in tissues with age and are present in endocrine tissues, making their catabolism essential for cellular homeostasis.
• Key enzymes such as D-amino acid oxidase (DAO) and D-aspartate oxidase (DDO) catalyze oxidative deamination of D-amino acids, producing hydrogen peroxide and α-keto acids.
• D-amino acid catabolism influences autophagy, redox signaling, and tumor suppression, as shown by DAO-mediated suppression of hepatocellular carcinoma.
• Analytical methods for D-amino acid catabolism include chiral separation and mass spectrometry, which are critical for measuring pathway activity in biological samples.
• D-amino acid-containing peptides and proteins are synthesized and degraded in a regulated manner, with implications for glioma targeting and peptide drug design.
Description
D-amino acids are the mirror-image enantiomers of the ubiquitous L-amino acids and have long been recognized as important molecules in bacterial cell walls, neuroendocrine tissues, and aged proteins. The Gene Ontology term GO:0019478, D-amino acid catabolic process, defines the set of biochemical reactions that result in the breakdown of these D-enantiomers, preventing their accumulation and recycling their carbon and nitrogen skeletons. Understanding this catabolic process is essential because D-amino acids are not simply metabolic waste; they participate in signaling, peptide synthesis, and disease progression, and their levels are tightly controlled by dedicated enzymes. Research into D-amino acid catabolism has accelerated due to advances in chiral analytical chemistry and the discovery that D-amino acid oxidase (DAO) can suppress hepatocellular carcinoma by oxidizing D-amino acids. In mammalian tissues, D-amino acids such as D-serine and D-aspartate are degraded by flavin adenine dinucleotide (FAD)-dependent oxidases, which generate hydrogen peroxide and α-keto acids, thereby linking catabolism to oxidative stress and autophagy. This pathway is also relevant to biotechnology and medicine, as D-amino acid-composed peptides are being developed for targeted cancer therapy, including glioma. The catabolic process is not a single reaction but a network of enzymatic steps that vary by tissue and substrate. For example, D-cysteine catabolism in cerebellar Purkinje cells produces hydrogen sulfide, which activates chaperone-mediated autophagy via Nrf2, illustrating how D-amino acid breakdown can directly modulate cell survival pathways. In endocrine tissues, D-amino acids are catabolized to regulate hormone secretion and tissue homeostasis. Thus, GO:0019478 encompasses a biologically significant set of reactions with broad implications for cancer, neurodegeneration, and metabolic research.
D-amino acid catabolic process At A Glance
| GO ID | GO:0019478 |
|---|---|
| GO term | D-amino acid catabolic process |
| Ontology | biological_process |
| Synonym | D-amino acid breakdown; D-amino acid catabolism; D-amino acid degradation |
| Definition | The chemical reactions and pathways resulting in the breakdown of D-amino acids, the D-enantiomers of amino acids. |
| Major function | Degradation of D-enantiomers of amino acids to maintain cellular homeostasis and prevent accumulation. |
| Key enzymes | D-amino acid oxidase (DAO), D-aspartate oxidase (DDO), and related flavoproteins. |
| Substrates | D-serine, D-aspartate, D-cysteine, D-alanine, and other D-amino acids. |
| Associated processes | Oxidative deamination, hydrogen peroxide production, autophagy regulation, and redox signaling. |
What Is GO:0019478?
GO:0019478 D-amino acid catabolic process is defined as the chemical reactions and pathways resulting in the breakdown of D-amino acids, the D-enantiomers of amino acids. In practical terms, this process includes enzymatic steps that convert D-amino acids into simpler metabolites, such as α-keto acids, ammonia, and hydrogen peroxide, through oxidative deamination or other catabolic routes. The term is a biological process in the Gene Ontology and is synonymous with D-amino acid breakdown, D-amino acid catabolism, and D-amino acid degradation.
Why Is D-amino acid catabolic process Important in Cell Biology?
D-amino acid catabolic process is critically important because it controls the levels of D-amino acids that would otherwise accumulate with age or in specific tissues, leading to altered protein function and cellular toxicity. The catabolic enzymes, particularly DAO, have been shown to suppress hepatocellular carcinoma by oxidizing D-amino acids, linking this pathway directly to cancer biology. Moreover, D-cysteine catabolism generates hydrogen sulfide, which activates chaperone-mediated autophagy in cerebellar Purkinje cells, highlighting a role in neuroprotection and protein quality control. In endocrine tissues, D-amino acid catabolism influences hormone secretion and tissue homeostasis. The pathway is also relevant to biotechnology, as D-amino acid-composed peptides are being engineered for targeted glioma therapy. Therefore, understanding GO:0019478 provides insights into metabolism, disease mechanisms, and therapeutic development.
• Prevents accumulation of D-amino acids in aged tissues, which can lead to protein damage and dysfunction.
• Regulates D-amino acid levels in endocrine tissues, affecting hormone secretion and tissue homeostasis.
• DAO-mediated catabolism suppresses hepatocellular carcinoma by oxidizing D-amino acids.
• D-cysteine catabolism produces hydrogen sulfide, activating chaperone-mediated autophagy and Nrf2 signaling in neurons.
• Provides a mechanism for D-amino acid clearance in the kidney and liver, protecting against D-amino acid toxicity.
• Enables the use of D-amino acid-composed peptides in targeted cancer therapy, such as glioma.
• Serves as a target for chiral drug design and metabolic engineering.
• Links to redox balance through the production of hydrogen peroxide during oxidative deamination.
• Involved in bacterial and eukaryotic metabolic pathways, with implications for microbiome-host interactions.
• Facilitates the study of D-amino acid dynamics using advanced analytical techniques like chiral separation.
What Happens During D-amino acid catabolic process?
Substrate recognition and uptake
In simple terms: The cell first identifies and takes in D-amino acids that need to be broken down.
D-amino acids can enter cells through specific transporters or be generated internally from D-amino acid-containing peptides and proteins. In mammalian tissues, D-amino acids such as D-serine and D-aspartate are recognized by flavin-containing oxidases, which exhibit stereospecificity for the D-enantiomer. The catabolic process begins when these substrates bind to the active site of enzymes like DAO or DDO, often in peroxisomes or mitochondria.
Oxidative deamination by D-amino acid oxidase
In simple terms: An enzyme called D-amino acid oxidase removes an ammonia group from the D-amino acid, producing a new molecule and hydrogen peroxide.
The central catabolic step for many D-amino acids is oxidative deamination catalyzed by D-amino acid oxidase (DAO), a FAD-dependent enzyme. DAO oxidizes D-amino acids to the corresponding α-keto acids, releasing ammonia and hydrogen peroxide. This reaction is stereospecific and is a major route for D-serine and D-alanine degradation in the kidney, liver, and brain. The hydrogen peroxide produced can act as a signaling molecule or cause oxidative stress if not detoxified.
D-aspartate oxidase and other catabolic enzymes
In simple terms: Other enzymes like D-aspartate oxidase break down different D-amino acids, such as D-aspartate.
D-aspartate oxidase (DDO) specifically catabolizes D-aspartate and D-glutamate, producing α-keto acids and hydrogen peroxide. DDO is localized in peroxisomes and is highly expressed in the brain and endocrine tissues, where it regulates D-aspartate levels. Additional enzymes, such as D-cysteine desulfhydrase, can catabolize D-cysteine to hydrogen sulfide, pyruvate, and ammonia, linking D-amino acid breakdown to gasotransmitter signaling.
Fate of catabolic products
In simple terms: The breakdown products are either used by the cell or removed as waste.
The α-keto acids generated from D-amino acid catabolism can enter central metabolic pathways, such as the citric acid cycle, to produce energy. Ammonia is detoxified via the urea cycle, while hydrogen peroxide is decomposed by catalase or glutathione peroxidase. In cerebellar Purkinje cells, hydrogen sulfide produced from D-cysteine catabolism activates chaperone-mediated autophagy through Nrf2, demonstrating that catabolic products can have specific signaling roles.
Regulation and integration with cellular stress responses
In simple terms: The breakdown process is controlled and can trigger stress responses that help the cell survive.
D-amino acid catabolism is regulated at the level of enzyme expression and substrate availability. For example, DAO expression is modulated in hepatocellular carcinoma, where it suppresses tumor growth by oxidizing D-amino acids. In neurons, D-cysteine catabolism activates the Nrf2 pathway, which induces antioxidant and autophagy genes, thereby integrating D-amino acid breakdown with cellular stress responses. This regulation ensures that D-amino acid levels are maintained within a narrow physiological range.
Key Genes Involved in GO:0019478 D-amino acid catabolic process
The following genes and proteins are experimentally implicated in D-amino acid catabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DAO | Encodes D-amino acid oxidase, catalyzing oxidative deamination of D-amino acids | Suppresses hepatocellular carcinoma; target for cancer metabolism studies |
| DDO | Encodes D-aspartate oxidase, catabolizing D-aspartate and D-glutamate | Regulates D-aspartate levels in brain and endocrine tissues |
| GOT1 | Glutamic-oxaloacetic transaminase 1, links α-keto acids to TCA cycle | Indirectly involved in processing D-amino acid catabolic products |
| GOT2 | Glutamic-oxaloacetic transaminase 2, mitochondrial | Metabolizes α-keto acids from D-amino acid breakdown |
| CAT | Catalase, detoxifies hydrogen peroxide produced by DAO/DDO | Protects cells from oxidative stress during D-amino acid catabolism |
| GPX1 | Glutathione peroxidase 1, reduces hydrogen peroxide | Modulates redox signaling from D-amino acid oxidation |
| Nrf2 (NFE2L2) | Transcription factor activated by hydrogen sulfide from D-cysteine catabolism | Mediates autophagy and antioxidant responses |
| SQSTM1 | p62, chaperone-mediated autophagy receptor | Linked to D-cysteine catabolic signaling in Purkinje cells |
| HSPA8 | HSC70, chaperone involved in chaperone-mediated autophagy | Effector of D-cysteine-induced autophagy |
| LAMP2A | Lysosome-associated membrane protein 2A, CMA receptor | Required for D-cysteine-induced autophagy |
| GRPR | Gastrin-releasing peptide receptor, targeted by D-amino acid peptides | Glioma targeting with D-amino acid-composed peptides |
| SLC7A11 | Cystine/glutamate antiporter, affects cysteine availability | Indirectly influences D-cysteine catabolism |
| CBS | Cystathionine beta-synthase, produces hydrogen sulfide | Cross-talk with D-cysteine catabolism |
| CTH | Cystathionine gamma-lyase, produces hydrogen sulfide | Alternative route for H2S generation from D-cysteine |
| MPST | Mercaptopyruvate sulfurtransferase, H2S production | Modulates D-cysteine catabolic signaling |
| GCLC | Glutamate-cysteine ligase catalytic subunit, glutathione synthesis | Responds to oxidative stress from D-amino acid catabolism |
| GCLM | Glutamate-cysteine ligase modifier subunit | Regulates glutathione levels during D-amino acid oxidation |
| SOD1 | Superoxide dismutase 1, antioxidant defense | Protects against ROS from D-amino acid catabolism |
How Is D-amino acid catabolic process Regulated?
D-amino acid catabolic process is regulated at multiple levels. Enzyme expression, particularly of DAO and DDO, is tissue-specific and can be modulated by hormones and metabolic status. In hepatocellular carcinoma, DAO expression is downregulated, and its restoration suppresses tumor growth by oxidizing D-amino acids, indicating that DAO is a tumor suppressor. In cerebellar Purkinje cells, D-cysteine catabolism generates hydrogen sulfide, which activates Nrf2, leading to upregulation of antioxidant and autophagy genes, including SQSTM1 and LAMP2A. This creates a feedback loop where catabolic activity influences cellular stress responses. Additionally, substrate availability, such as D-serine and D-aspartate levels, is controlled by synthesis and transport, indirectly regulating catabolic flux. The pathway is also integrated with redox homeostasis, as hydrogen peroxide produced during oxidation is detoxified by catalase and glutathione peroxidases.
D-amino acid catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DAO | Hepatocellular carcinoma suppression | DAO knockout or overexpression in liver cancer cell lines |
| DDO | Neurodegeneration and D-aspartate accumulation | DDO knockout mice or neuronal cell models |
| Nrf2 (NFE2L2) | Autophagy and oxidative stress in neurons | Nrf2 knockout or knock-in in Purkinje cell models |
| GRPR | Glioma targeting with D-amino acid peptides | GRPR-overexpressing glioma xenografts |
| CAT | Oxidative stress from D-amino acid catabolism | Catalase knockout or overexpression in hepatocytes |
Hepatocellular carcinoma
D-amino acid oxidase (DAO) suppresses hepatocellular carcinoma by oxidizing D-amino acids, and its downregulation is associated with tumor progression. This suggests that D-amino acid catabolic process acts as a metabolic barrier against liver cancer, and restoring DAO activity could be a therapeutic strategy.
Neurodegeneration and autophagy
In cerebellar Purkinje cells, D-cysteine catabolism produces hydrogen sulfide, which activates chaperone-mediated autophagy via Nrf2, protecting against neurodegeneration. Dysregulation of this pathway may contribute to impaired protein quality control and neuronal death. Additionally, D-amino acids accumulate in aged tissues, potentially contributing to age-related neurodegeneration.
Endocrine disorders
D-amino acids are present in endocrine tissues, where their catabolism regulates hormone secretion and tissue homeostasis. Alterations in D-amino acid catabolic enzymes may affect endocrine function, although specific disease links require further investigation.
Glioma and targeted therapy
D-amino acid-composed peptides targeting GRPR have been developed for glioma therapy, exploiting the stability and specificity of D-amino acids. While this is not directly about catabolism, it highlights the therapeutic potential of D-amino acid biochemistry in cancer.
From D-amino acid catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does DAO suppress tumor growth via D-amino acid oxidation? | DAO knockout and overexpression in hepatocellular carcinoma cell lines |
| How does D-cysteine catabolism activate autophagy? | D-cysteine treatment in cerebellar Purkinje cell cultures with Nrf2 knockout |
| What is the role of DDO in D-aspartate clearance? | DDO knockout mouse models and neuronal cell lines |
| Can D-amino acid-composed peptides target glioma? | GRPR-overexpressing glioma xenografts treated with D-peptides |
| How does age affect D-amino acid accumulation? | Aged tissue samples and longitudinal animal models |
| What is the metabolic fate of α-keto acids from D-amino acids? | Isotope tracing in hepatocytes with DAO knockout |
How to Study the D-amino acid catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Chiral HPLC-MS | D-amino acid and metabolite levels | Quantifying catabolic flux in tissues |
| DAO activity assay | Hydrogen peroxide production or oxygen consumption | Screening for enzyme modulators |
| CRISPR knockout | Loss of gene function | Causal studies of DAO, DDO, Nrf2 |
| Overexpression | Gain of gene function | Rescue experiments and tumor suppression |
| Western blot | Protein expression levels | Validating knockout or overexpression |
| Autophagy flux assay | LAMP2A and HSPA8 levels | Measuring chaperone-mediated autophagy |
| Nrf2 reporter assay | Nrf2 transcriptional activity | Assessing oxidative stress response |
| Isotope tracing | Metabolic fate of D-amino acids | Tracing α-keto acid entry into TCA cycle |
Chiral separation and mass spectrometry
Chiral separation techniques, such as HPLC with chiral columns, combined with mass spectrometry, are essential for quantifying D-amino acids and their catabolic products in biological samples. These methods allow researchers to measure the activity of D-amino acid catabolic enzymes by monitoring substrate depletion and product formation.
Enzymatic assays for DAO and DDO activity
DAO and DDO activity can be assayed by measuring hydrogen peroxide production or oxygen consumption using colorimetric or fluorometric probes. These assays are typically performed in tissue homogenates or purified enzyme preparations and are useful for screening inhibitors or activators of D-amino acid catabolism.
Genetic knockout and overexpression models
CRISPR-Cas9 knockout of DAO, DDO, or Nrf2 in cell lines and animal models enables causal studies of D-amino acid catabolic process. Overexpression of these genes can rescue phenotypes and confirm specificity. Such models are critical for linking catabolic activity to disease outcomes.
Autophagy and redox signaling assays
Chaperone-mediated autophagy can be monitored using LAMP2A and HSPA8 markers, while redox status is assessed by measuring glutathione, hydrogen sulfide, and Nrf2 target gene expression. These methods reveal how D-amino acid catabolism integrates with cellular stress responses.
How CRISPR Can Be Used to Study GO:0019478 D-amino acid catabolic process
Knockout
CRISPR-Cas9 knockout of DAO, DDO, or Nrf2 is used to study loss of D-amino acid catabolic function. For example, DAO knockout in hepatocellular carcinoma cells increases D-amino acid levels and promotes tumor growth, confirming its tumor-suppressive role. DDO knockout in neurons leads to D-aspartate accumulation, affecting neurotransmission.
Point Mutation
Point mutations can be introduced into the active site of DAO or DDO to dissect catalytic residues and substrate specificity. Such models help determine whether enzymatic activity is required for tumor suppression or autophagy activation.
Knock-in
Knock-in of tagged DAO or DDO (e.g., FLAG or GFP) allows visualization and immunoprecipitation of the enzymes in their native context. This is useful for studying subcellular localization and interacting partners during D-amino acid catabolism.
Overexpression
Overexpression of DAO or DDO via CRISPR activation or lentiviral vectors can rescue catabolic defects and suppress tumor growth. Overexpression models are also used to study the effects of enhanced D-amino acid breakdown on autophagy and redox balance.
How EDITGENE Supports D-amino acid catabolic process Research
Researchers studying D-amino acid catabolic process-related genes often need to determine whether a candidate gene is causally involved in substrate degradation, metabolite production, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for D-amino acid catabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| DAO Knockout HEK293 Cell Line | EDJ-KQ4419 | Human | 1610 | Details Get a Quote |
| DDO Knockout HEK293 Cell Line | EDJ-KQ5576 | Human | 8528 | Details Get a Quote |
| DAO Knockout HeLa Cell Line | EDJ-KQ53068 | Human | 1610 | Details Get a Quote |
| DDO Knockout HeLa Cell Line | EDJ-KQ54930 | Human | 8528 | Details Get a Quote |
| DAO Knockout A-549 Cell Line | EDJ-KQ61533 | Human | 1610 | Details Get a Quote |
| DDO Knockout A-549 Cell Line | EDJ-KQ63416 | Human | 8528 | Details Get a Quote |
| DAO Knockout HCT 116 Cell Line | EDJ-KQ70026 | Human | 1610 | Details Get a Quote |
| DDO Knockout HCT 116 Cell Line | EDJ-KQ71880 | Human | 8528 | Details Get a Quote |
Displaying Records 1 To 8 Of 8 Records
Frequently Asked Questions About D-amino acid catabolic process
What is D-amino acid catabolic process?
D-amino acid catabolic process (GO:0019478) is the set of biochemical reactions that break down D-enantiomers of amino acids, such as D-serine and D-aspartate, into simpler metabolites like α-keto acids, ammonia, and hydrogen peroxide.
What genes are involved in D-amino acid catabolic process?
Key genes include DAO (D-amino acid oxidase), DDO (D-aspartate oxidase), and NFE2L2 (Nrf2), which regulate the breakdown of D-amino acids and downstream stress responses.
Why is D-amino acid catabolism important in cancer?
DAO-mediated catabolism suppresses hepatocellular carcinoma by oxidizing D-amino acids, and its downregulation is associated with tumor progression.
How are D-amino acids measured in biological samples?
Chiral separation techniques coupled with mass spectrometry are used to quantify D-amino acids and their catabolic products in tissues and body fluids.
What is the role of D-cysteine in autophagy?
D-cysteine catabolism produces hydrogen sulfide, which activates chaperone-mediated autophagy in cerebellar Purkinje cells via Nrf2 signaling.
Do D-amino acids accumulate with age?
Yes, D-amino acids accumulate in elderly tissues, and their catabolism is important for preventing age-related protein damage.
What enzymes catalyze D-amino acid breakdown?
D-amino acid oxidase (DAO) and D-aspartate oxidase (DDO) are the primary flavoenzymes that catalyze oxidative deamination of D-amino acids.
How can CRISPR be used to study D-amino acid catabolism?
CRISPR knockout, knock-in, and overexpression models of DAO, DDO, and Nrf2 allow causal studies of D-amino acid catabolic process in cancer and neuronal cells.
What diseases are linked to D-amino acid catabolic process?
Hepatocellular carcinoma, neurodegeneration, and endocrine disorders have been linked to alterations in D-amino acid catabolism.
Where does D-amino acid catabolism occur in the cell?
It occurs primarily in peroxisomes and mitochondria, where DAO and DDO are localized, and involves cytosolic steps for product processing.
Conclusion
GO:0019478 D-amino acid catabolic process is a vital metabolic pathway that controls the levels of D-enantiomers of amino acids, preventing their accumulation and linking to cancer suppression, autophagy, and endocrine function. The pathway is catalyzed by stereospecific enzymes such as DAO and DDO, and its activity can be measured using advanced chiral analytical methods. Dysregulation of D-amino acid catabolism contributes to hepatocellular carcinoma and neurodegeneration, making it a promising target for therapeutic intervention. Researchers can leverage CRISPR-based models to dissect the causal roles of DAO, DDO, and Nrf2 in D-amino acid catabolic process, and to identify novel regulators through library screening. EDITGENE provides end-to-end services to support these studies, from knockout and knock-in cell line generation to bioinformatics analysis, accelerating discoveries in this emerging field.
References
- 1. Ling X et al.. 2026. A Novel d-Amino Acid-Composed GRPR-Targeted Peptide in Glioma.. Mol Pharm 23(2):711-720 PMID: 41496522
- 2. Li Z et al.. 2025. D-amino acid oxidase suppresses hepatocellular carcinoma via oxidizing D-amino acids.. J Transl Med 23(1):1359 PMID: 41299678
- 3. Kato H et al.. 2024. Assaying D-Amino Acid in Japanese Sake Using L-Amino Acid Derivatizing Agent.. Methods Mol Biol 2851:125-131 PMID: 39210177
- 4. Fujii N. 2005. D-amino acid in elderly tissues.. Biol Pharm Bull 28(9):1585-9 PMID: 16141520
- 5. Ollivaux C et al.. 2014. Biogenesis of D-amino acid containing peptides/proteins: where, when and how?. J Pept Sci 20(8):595-612 PMID: 24895293
- 6. Chieffi Baccari G et al.. 2020. D-Amino acids in mammalian endocrine tissues.. Amino Acids 52(9):1263-1273 PMID: 32930873
- 7. Ueda E et al.. 2022. D-Cysteine Activates Chaperone-Mediated Autophagy in Cerebellar Purkinje Cells via the Generation of Hydrogen Sulfide and Nrf2 Activation.. Cells 11(7) PMID: 35406792
- 8. Szökő É et al.. 2016. Chiral separations for d-amino acid analysis in biological samples.. J Pharm Biomed Anal 130:100-109 PMID: 27435607
